Home/Pipeline/Colibri TAVI System (Second-Generation)

Colibri TAVI System (Second-Generation)

Aortic Stenosis

Feasibility StudyActive

Key Facts

Indication
Aortic Stenosis
Phase
Feasibility Study
Status
Active
Company

About Colibri Heart Valve

Colibri Heart Valve is an emerging, pre-revenue medical device company developing a disruptive, ready-for-use TAVI system for aortic valve replacement. Its core innovation is a pre-mounted, pre-crimped valve utilizing dry tissue technology, which aims to reduce procedural complexity, improve quality control, and enable a lower delivery profile compared to incumbent systems. The company is in the clinical development stage, having initiated a feasibility study for its second-generation system in 2018, and is positioned to address significant operational inefficiencies in the rapidly growing transcatheter heart valve market.

View full company profile